FDA Says Bayer Failed to Reveal Lethal Drug Risks–but Fails to Change Licensure or Label_NYT
FDA issued an advisory stating that the concealed study results demonstrate "that use of Trasylol may increase the chance for death, serious kidney damage, congestive heart failure and strokes."